Hoenle AG (ETR:HNL)
Germany
· Delayed Price · Currency is EUR | Market Cap | 54.07M |
| Revenue (ttm) | 94.14M |
| Net Income (ttm) | -4.11M |
| Shares Out | 6.06M |
| EPS (ttm) | -0.68 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 280 |
| Average Volume | 4,441 |
| Open | 8.96 |
| Previous Close | 8.92 |
| Day's Range | 8.92 - 8.98 |
| 52-Week Range | 6.48 - 11.90 |
| Beta | 1.47 |
| RSI | 47.47 |
| Earnings Date | May 19, 2026 |
About Hoenle AG
Hoenle AG develops, manufactures, and distributes industrial UV technologies and systems in Germany and internationally. It operates through three segments: Adhesive Systems, Curing, and Disinfection. The Adhesives Systems segment offers industrial adhesives, as well as supplies adhesive curing systems used for consumer electronics, automotive, optics and opto-electronics, and curing of adhesives applications. The Curing segment sells equipment for surface drying and curing paints, varnishes, and other coatings for printing, packaging printing,... [Read more]
Financial Performance
In fiscal year 2025, Hoenle AG's revenue was 94.00 million, a decrease of -4.82% compared to the previous year's 98.76 million. Losses were -3.17 million, -76.15% less than in 2024.
Financial StatementsNews
Hoenle AG Earnings Call Transcript: Q1 2026
Revenue and EBITDA were flat to slightly down year-over-year amid industry-wide reluctance, with Disinfection showing strong growth. Management maintains full-year guidance, expecting improved performance in the second half as order intake and after-sales activities increase.
Mixed Q3, FY guidance lowered but prospect remain attractive
Dr. Hönle reported Q3 revenue down 5.5% to €22.4m amid weak demand, particularly in adhesives. New FY24/25 guidance lowered; BUY with €16 price target. Jetzt den vollständigen Artikel lesen